Urinary cotinine concentration confirms the reduced risk of preeclampsia with tobacco exposure


      Objective: We assessed tobacco exposure in nulliparous women with preeclampsia compared with that in control subjects by measuring urinary cotinine to confirm the reduced risk of preeclampsia associated with tobacco exposure during pregnancy. Study Design: A case-control study group of 50 women with preeclampsia after 35 weeks of gestation and a group of 50 control subjects matched for gestational age, date of delivery, and body mass index were selected from the project database. Urine obtained on admission was assayed for cotinine. Self-reported smoking information was blinded during patient selection and laboratory assay. Results: Thirty-five patients had detectable urinary cotinine levels, 11 (22%) with preeclampsia and 24 (48%) control women. Mean cotinine concentrations among exposed women were 331 ng/mL for those with preeclampsia and 540 ng/mL for control subjects. The odds ratio of preeclampsia developing in an exposed woman was 0.31 (95% confidence interval, 0.12-0.79). Conclusion: These findings, obtained by using laboratory assay, confirm the reduced risk of developing preeclampsia with tobacco exposure. (Am J Obstet Gynecol 1999;181:1192-6.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American College of Obstetricians and Gynecologists
        Hypertension in pregnancy.
        The College, Washington1996 (Technical Bulletin No.: 219)
        • Underwood PB
        • Kesler KF
        • O’Lane JM
        • Callagan DA.
        Parental smoking empirically related to pregnancy outcome.
        Obstet Gynecol. 1967; 29: 1-8
        • Duffus GM
        • MacGillivray I.
        The incidence of pre-eclamptic toxaemia in smokers and non-smokers.
        Lancet. 1968; 1: 994-995
        • Palmgren B
        • Wahlen T
        • Wallander B.
        Toxaemia and cigarette smoking during pregnancy: prospective consecutive investigation of 3927 pregnancies.
        Acta Obstet Gynecol Scand. 1973; 52: 183-185
        • Marcoux S
        • Brisson J
        • Fabia J.
        The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension.
        Am J Epidemiol. 1989; 130: 950-957
        • Eskenazi B
        • Fenster L
        • Sidney S.
        A multivariate analysis of risk factors for preeclampsia.
        JAMA. 1991; 266: 237-241
        • Savitz DA
        • Zhang J.
        Pregnancy-induced hypertension in North Carolina, 1988-1989.
        Am J Public Health. 1992; 82: 675-679
        • Sibai BM
        • Gordon T
        • Thom E
        • Caritis SN
        • Klebanoff M
        • McNellis D
        • et al.
        Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study.
        Am J Obstet Gynecol. 1995; 172: 642-648
        • Mittendorf R
        • Lain KY
        • Williams MA
        • Walker CK.
        Preeclampsia: a nested, case-control study of risk factors and their interactions.
        J Reprod Med. 1996; 41: 491-496
        • Hubel CA
        • McLaughlin MK
        • Evans RW
        • Hauth BA
        • Sims CJ
        • Roberts JM.
        Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum.
        Am J Obstet Gynecol. 1996; 174: 975-982
        • Harlharan M
        • VanNoord T
        • Greden JF.
        A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma.
        Clin Chem. 1988; 34: 724-729
        • Jarvis MJ
        • Russel MAH
        • Benowitz NL
        • Feyerabend C.
        Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.
        Am J Public Health. 1988; 78: 696-698
        • Fleiss JL.
        Statistical methods for rates and proportions.
        John Wiley, New York1981
        • Wilcox RG
        • Hughes J
        • Roland J.
        Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements.
        BMJ. 1979; 2: 1026-1028
        • Zeidenberg P
        • Jaffe JH
        • Kanzler M
        • Levitt MD
        • Langone JJ
        • Van Vunakis HV.
        Nicotine: cotinine levels in blood during cessation of smoking.
        Compr Psychiatry. 1977; 18: 93-101
        • Bardy AH
        • Seppala T
        • Lillsunde P
        • Kataja JM
        • Koskela P
        • Pikkarainen J
        • et al.
        Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking.
        Br J Obstet Gynaecol. 1993; 100: 721-726
        • Haddow JE
        • Knight GJ
        • Palomaki GE
        • Kloza EM
        • Wald NJ.
        Cigarette consumption and serum cotinine in relation to birthweight.
        Br J Obstet Gynaecol. 1987; 94: 678-681
        • Sibai BM
        • Ewell M
        • Levine RJ
        • Klebanoff MA
        • Esterlitz J
        • Catalano PM
        • et al.
        Risk factors associated with preeclampsia in healthy nulliparous women.
        Am J Obstet Gynecol. 1997; 177: 1003-1010
        • Benowitz NL
        • Fitzgerald GA
        • Wilson M
        • Zhang Q.
        Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
        J Am Coll Cardiol. 1993; 22: 1159-1167
        • Donnenfeld AE
        • Pulkkinen A
        • Palomaki GE
        • Knight GJ
        • Haddow JE.
        Simultaneous fetal and maternal cotinine levels in pregnant women smokers.
        Am J Obstet Gynecol. 1993; 168: 781-782
        • Roberts JM
        • Taylor RN
        • Musci TJ
        • Rodgers GM
        • Hubel CA
        • McLaughlin MK.
        Preeclampsia: an endothelial cell disorder.
        Am J Obstet Gynecol. 1989; 161: 1200-1204
        • Kamisaki Y
        • Wada K
        • Nakamoto K
        • Kishimoto Y
        • Ashida K
        • Itoh T.
        Substances in the aqueous fraction of cigarette smoke inhibit lipid peroxidation in synaptosomes of rat cerebral cortex.
        Biochem Mol Biol Int. 1997; 42: 1-10
        • Vince GS
        • Starkey PM
        • Austgulen R
        • Kwiatkowski D
        • Redman CW.
        Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia.
        Br J Obstet Gynaecol. 1995; 102: 20-25
        • Holt PG.
        Immune and inflammatory function in cigarette smokers.
        Thorax. 1987; 42: 241-249
        • Cnattingius S
        • Mils JL
        • Yuen J
        • Eriksson O
        • Ros HS.
        The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction.
        Am J Obstet Gynecol. 1997; 177: 156-161